BACKGROUND: There is a marked male preponderance in autism spectrum conditions. The extreme male brain theory and the fetal androgen theory of autism suggest that elevated prenatal testosterone exposure is a key contributor to autistic traits. The current paper reports findings from two separate studies that test this hypothesis. METHODS: A parent-report questionnaire, the Childhood Autism Spectrum Test (CAST), was employed to measure autistic traits in both studies. The first study examined autistic traits in young children with congenital adrenal hyperplasia (CAH), a condition causing unusually high concentrations of testosterone prenatally in girls. Eighty one children with CAH (43 girls) and 72 unaffected relatives (41 girls), aged 4-11 years, were assessed. The second study examined autistic traits in relation to amniotic testosterone in 92 typically developing children (48 girls), aged 3-5 years. RESULTS: Findings from neither study supported the association between prenatal androgen (testosterone) exposure and autistic traits. Specifically, young girls with and without CAH did not differ significantly in CAST scores and amniotic testosterone concentrations were not significantly associated with CAST scores in boys, girls, or the whole sample. CONCLUSIONS: These studies do not support a relationship between prenatal testosterone exposure and autistic traits. These findings augment prior research suggesting no consistent relationship between early androgen exposure and autistic traits.
BACKGROUND: There is a marked male preponderance in autism spectrum conditions. The extreme male brain theory and the fetal androgen theory of autism suggest that elevated prenatal testosterone exposure is a key contributor to autistic traits. The current paper reports findings from two separate studies that test this hypothesis. METHODS: A parent-report questionnaire, the Childhood Autism Spectrum Test (CAST), was employed to measure autistic traits in both studies. The first study examined autistic traits in young children with congenital adrenal hyperplasia (CAH), a condition causing unusually high concentrations of testosterone prenatally in girls. Eighty one children with CAH (43 girls) and 72 unaffected relatives (41 girls), aged 4-11 years, were assessed. The second study examined autistic traits in relation to amniotic testosterone in 92 typically developing children (48 girls), aged 3-5 years. RESULTS: Findings from neither study supported the association between prenatal androgen (testosterone) exposure and autistic traits. Specifically, young girls with and without CAH did not differ significantly in CAST scores and amniotic testosterone concentrations were not significantly associated with CAST scores in boys, girls, or the whole sample. CONCLUSIONS: These studies do not support a relationship between prenatal testosterone exposure and autistic traits. These findings augment prior research suggesting no consistent relationship between early androgen exposure and autistic traits.
Authors: Esha S L Jamnadass; Jeffrey A Keelan; Lauren P Hollier; Martha Hickey; Murray T Maybery; Andrew J O Whitehouse Journal: J Neurodev Disord Date: 2015-06-07 Impact factor: 4.025
Authors: Jeffrey A Keelan; Eugen Mattes; HaiWei Tan; Andrew Dinan; John P Newnham; Andrew J O Whitehouse; Peter Jacoby; Martha Hickey Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240
Authors: Amos Nadler; Colin F Camerer; David T Zava; Triana L Ortiz; Neil V Watson; Justin M Carré; Gideon Nave Journal: Proc Biol Sci Date: 2019-09-04 Impact factor: 5.349
Authors: Debra Spencer; Vickie Pasterski; Sharon Neufeld; Vivette Glover; Thomas G O'Connor; Peter C Hindmarsh; Ieuan A Hughes; Carlo L Acerini; Melissa Hines Journal: Horm Behav Date: 2017-11-01 Impact factor: 3.587
Authors: Debra Spencer; Vickie Pasterski; Sharon A S Neufeld; Vivette Glover; Thomas G O'Connor; Peter C Hindmarsh; Ieuan A Hughes; Carlo L Acerini; Melissa Hines Journal: Horm Behav Date: 2020-11-19 Impact factor: 3.587
Authors: Ran S Rotem; Vy T Nguyen; Gabriel Chodick; Michael Davidovitch; Varda Shalev; Russ Hauser; Brent A Coull; Andrea Bellavia; Marc G Weisskopf Journal: Am J Epidemiol Date: 2021-04-06 Impact factor: 4.897